Overview

RN624 In Adult Patients With Chronic Low Back Pain

Status:
Completed
Trial end date:
2008-09-02
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the analgesic efficacy of RN624 compared with placebo and compared with naproxen in the treatment of adult patients with chronic low back pain.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Naproxen
Tanezumab